Literature DB >> 10905631

Retinal structure and function in an animal model that replicates the biochemical hallmarks of desmosterolosis.

S J Fliesler1, M J Richards, C Miller, N S Peachey, R J Cenedella.   

Abstract

Desmosterolosis is a rare, autosomal recessive, human disease characterized by multiple congenital anomalies in conjunction with grossly elevated levels of desmosterol and markedly reduced levels of cholesterol in all bodily tissues. Herein, we evaluated retinal sterol composition, histology, and electrophysiological function in an animal model that exhibited the biochemical features of desmosterolosis, produced by treating pregnant rats and their progeny with U18666A, an inhibitor of desmosterol reductase. Treated rats had cataracts, were substantially smaller, and had markedly high levels of desmosterol and profoundly low levels of cholesterol in their retinas and other tissues compared to age-matched controls. However, their retinas were histologically normal and electrophysiologically functional. These results suggest that desmosterol may be able to replace cholesterol in the retina, both structurally and functionally. These findings are discussed in the context of "sterol synergism".

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10905631      PMCID: PMC2844951          DOI: 10.1023/a:1007519321917

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  47 in total

1.  [TERATOGENIC ACTION OF TRIPARANOL IN ANIMALS].

Authors:  C ROUX
Journal:  Arch Fr Pediatr       Date:  1964-04

2.  A NEWLY RECOGNIZED SYNDROME OF MULTIPLE CONGENITAL ANOMALIES.

Authors:  D W SMITH; L LEMLI; J M OPITZ
Journal:  J Pediatr       Date:  1964-02       Impact factor: 4.406

3.  AGENTS AFFECTING LIPID METABOLISM. XV. BIOCHEMICAL STUDIES WITH THE CHOLESTEROL BIOSYNTHESIS INHIBITOR AY-9944 IN YOUNG AND MATURE RATS.

Authors:  M L GIVNER; D DVORNIK
Journal:  Biochem Pharmacol       Date:  1965-04       Impact factor: 5.858

4.  Triparanol-induced Cataract in Rats.

Authors:  L von Sallmann; P Grimes; E Collins
Journal:  Trans Am Ophthalmol Soc       Date:  1963

Review 5.  The Smith-Lemli-Opitz syndrome: a potentially fatal birth defect caused by a block in the last enzymatic step in cholesterol biosynthesis.

Authors:  G S Tint; A K Batta; G Xu; S Shefer; A Honda; M Irons; E R Elias; G Salen
Journal:  Subcell Biochem       Date:  1997

6.  Teratogenic effect of AY 9944 in rats: importance of the day of administration and maternal plasma cholesterol level.

Authors:  V Barbu; C Roux; R Dupuis; J Gardette; J C Maziere
Journal:  Proc Soc Exp Biol Med       Date:  1984-05

Review 7.  Lipid fluidity and membrane protein dynamics.

Authors:  G Lenaz
Journal:  Biosci Rep       Date:  1987-11       Impact factor: 3.840

8.  Clinical phenotype of desmosterolosis.

Authors:  D R FitzPatrick; J W Keeling; M J Evans; A E Kan; J E Bell; M E Porteous; K Mills; R M Winter; P T Clayton
Journal:  Am J Med Genet       Date:  1998-01-13

9.  Induction of chronic epileptiform activity in the rat by an inhibitor of cholesterol synthesis, U18666A.

Authors:  G G Bierkamper; R J Cenedella
Journal:  Brain Res       Date:  1978-07-14       Impact factor: 3.252

10.  Sterol synergism in Paramecium tetraurelia.

Authors:  B D Whitaker; D L Nelson
Journal:  J Gen Microbiol       Date:  1988-06
View more
  8 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

Review 2.  The ins and outs of cholesterol in the vertebrate retina.

Authors:  Steven J Fliesler; Lionel Bretillon
Journal:  J Lipid Res       Date:  2010-09-22       Impact factor: 5.922

3.  Light-induced exacerbation of retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Dana K Vaughan; Neal S Peachey; Michael J Richards; Blake Buchan; Steven J Fliesler
Journal:  Exp Eye Res       Date:  2005-12-19       Impact factor: 3.467

4.  7-Dehydrocholesterol-derived oxysterols and retinal degeneration in a rat model of Smith-Lemli-Opitz syndrome.

Authors:  Libin Xu; Lowell G Sheflin; Ned A Porter; Steven J Fliesler
Journal:  Biochim Biophys Acta       Date:  2012-03-09

5.  Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

Authors:  Frances M Platt; Christopher Wassif; Alexandria Colaco; Andrea Dardis; Emyr Lloyd-Evans; Bruno Bembi; Forbes D Porter
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

6.  Apolipoprotein E allele-dependent pathogenesis: a model for age-related retinal degeneration.

Authors:  G Malek; L V Johnson; B E Mace; P Saloupis; D E Schmechel; D W Rickman; C A Toth; P M Sullivan; C Bowes Rickman
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-03       Impact factor: 11.205

Review 7.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

8.  Retinal degeneration in a rodent model of Smith-Lemli-Opitz syndrome: electrophysiologic, biochemical, and morphologic features.

Authors:  Steven J Fliesler; Neal S Peachey; Michael J Richards; Barbara A Nagel; Dana K Vaughan
Journal:  Arch Ophthalmol       Date:  2004-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.